Changes in ovarian cancer survival during the 20 years before the era of targeted therapy

Abstract

Survival outcomes have improved for serous and endometrioid epithelial ovarian cancer in the last 20 years. However, no improvement was observed for patients with mucinous and clear cell carcinoma subtypes.